Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Summit Therapeu ADR (SMMT)

Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,731,282
  • Shares Outstanding, K 737,448
  • Annual Sales, $ 0 K
  • Annual Income, $ -614,930 K
  • EBIT $ -197 M
  • EBITDA $ -195 M
  • 60-Month Beta -0.92
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 33.68

Options Overview Details

View History
  • Implied Volatility 85.81% ( +9.26%)
  • Historical Volatility 84.42%
  • IV Percentile 8%
  • IV Rank 17.29%
  • IV High 283.55% on 02/09/24
  • IV Low 44.48% on 01/10/24
  • Put/Call Vol Ratio 0.16
  • Today's Volume 990
  • Volume Avg (30-Day) 2,581
  • Put/Call OI Ratio 0.91
  • Today's Open Interest 76,169
  • Open Int (30-Day) 79,891

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.08
  • Number of Estimates 2
  • High Estimate -0.07
  • Low Estimate -0.08
  • Prior Year -0.05
  • Growth Rate Est. (year over year) -60.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.03 +2.16%
on 11/21/24
22.90 -19.56%
on 10/28/24
-2.08 (-10.15%)
since 10/21/24
3-Month
11.76 +56.63%
on 09/05/24
33.89 -45.65%
on 09/16/24
+5.08 (+38.08%)
since 08/21/24
52-Week
1.89 +874.60%
on 11/30/23
33.89 -45.65%
on 09/16/24
+16.44 (+830.30%)
since 11/21/23

Most Recent Stories

More News
MarketBeat Week in Review – 11/4 - 11/8

Markets rallied strongly this week on clarity about the election and an expected rate cut, but next week's inflation readings will determine if momentum lasts

NVDA : 146.67 (+0.53%)
SMMT : 18.42 (-1.07%)
MRK : 99.86 (+2.48%)
ALT : 8.40 (+4.41%)
ENVX : 9.10 (+1.00%)
CCL : 25.35 (+1.08%)
COIN : 295.23 (-7.74%)
BMY : 58.23 (+0.60%)
FSLR : 181.95 (-1.56%)
SOUN : 6.98 (+8.39%)
QCOM : 155.46 (+0.77%)
INTC : 24.44 (+1.79%)
2 Hot Biopharma Stocks to Buy and Hold for 5 Years

If you're patient, these businesses have a lot of promising projects in the works.

SMMT : 18.42 (-1.07%)
MRK : 99.86 (+2.48%)
Why Summit Therapeutics Stock Was a Winner Today

A cancer drug has vast potential for the company, says a pundit newly following it.

$SPX : 5,948.71 (+0.53%)
SMMT : 18.42 (-1.07%)
Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?

Summit Therapeutics Inc. aims to advance Ivonescimab, a potential breakthrough for NSCLC. The FDA's Fast Track designation boosts its U.S. clinical pathway.

SMMT : 18.42 (-1.07%)
MRK : 99.86 (+2.48%)
3 Magnificent Stocks Under $100 to Buy in November

The price could be right for these stocks.

AZN : 64.26 (+1.68%)
SMMT : 18.42 (-1.07%)
MRK : 99.86 (+2.48%)
EXEL : 34.83 (+0.52%)
2 Dividend Stocks to Buy for a Lifetime of Passive Income

These are the kinds of stocks that can allow investors to sleep easy at night.

MRK : 99.86 (+2.48%)
SMMT : 18.42 (-1.07%)
MDT : 84.74 (+0.75%)
MRNA : 38.25 (+3.55%)
ISRG : 550.62 (+1.62%)
3 Stocks That Have Generated 1,000% Returns in Just 2 Years

Should you add these fast-growing stocks to your portfolio?

NVDA : 146.67 (+0.53%)
SMMT : 18.42 (-1.07%)
CVNA : 248.38 (+1.59%)
Is Summit Therapeutics a Millionaire Maker?

The potential upside of this stock is undeniably meaty.

SMMT : 18.42 (-1.07%)
Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising?

This drugmaker's lead candidate could become a top-selling cancer therapy.

TIL : 24.76 (+5.99%)
SMMT : 18.42 (-1.07%)
BNTX : 108.23 (+5.96%)
Billionaire Israel Englander Just Quietly Took a Stake in This Potentially Lucrative Pharmaceutical Stock. Should You?

Millennium Management just initiated a position in a small biotech company developing a new cancer drug.

SMMT : 18.42 (-1.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Summit Therapeutics PLC is engaged in the discovery and development of drug to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics PLC is headquartered in Abingdon, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 21.28
2nd Resistance Point 20.63
1st Resistance Point 19.62
Last Price 18.42
1st Support Level 17.96
2nd Support Level 17.31
3rd Support Level 16.30

See More

52-Week High 33.89
Fibonacci 61.8% 21.67
Last Price 18.42
Fibonacci 50% 17.89
Fibonacci 38.2% 14.11
52-Week Low 1.89

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar